From Nasdaq: 2025-05-26 12:42:00

BioSig Technologies, Inc. (BSGM) partners with Streamex Exchange Corporation for real-world asset tokenization, marking its entry into the blockchain sector. This strategic move aims to bring commodity markets on-chain, diversifying and positioning BioSig for growth in decentralized finance.

Shares of BSGM surged 24.4% post-announcement, closing at $5.28. The company’s year-to-date shares jumped 254.4%, outperforming the industry’s 10.5% decline. This shift to blockchain and digital assets could open new revenue streams and attract fintech investors, enhancing market relevance.

BSGM’s deal with Streamex involves full acquisition, with Streamex shareholders receiving 75% of BioSig’s diluted common stock. This agreement positions BioSig to leverage Streamex’s expertise in real-world asset tokenization, expanding its reach beyond traditional medtech into high-growth markets.

The global tokenization market is set to reach $5.6 billion by 2026, with a CAGR of 19.0%. Driven by demand for liquidity and transparency, blockchain technology enables digitization of real-world assets. BSGM’s alignment with Streamex enhances its capabilities in asset tokenization and market expansion.

BSGM’s Zacks Rank #2 reflects positive industry prospects. Other top-ranked medical stocks like CVS Health, Integer Holdings, and AngioDynamics have reported strong earnings performance, showcasing growth potential and investor interest in the sector. These companies offer promising investment opportunities for the future.



Read more at Nasdaq: BioSig Stock Surges Following Share Exchange Deal With Streamex